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ABSTRACT
Introduction Substantial variation in the delivery of hip 
fracture care, and patient outcomes persists between 
hospitals, despite established UK national standards 
and guidelines. Patients’ outcomes are partly explained 
by patient- level risk factors, but it is hypothesised that 
organisational- level factors account for the persistence of 
unwarranted variation in outcomes. The mixed- methods 
REducing unwarranted variation in the Delivery of high 
qUality hip fraCture services in England and Wales 
(REDUCE) study, aims to determine key organisational 
factors to target to improve patient care.
Methods and analysis Quantitative analysis will assess 
the outcomes of patients treated at 172 hospitals in 
England and Wales (2016–2019) using National Hip 
Fracture Database data combined with English Hospital 
Episodes Statistics; Patient Episode Database for Wales; 
Civil Registration (deaths) and multiple organisational- 
level audits to characterise each service provider. 
Statistical analyses will identify which organisational 
factors explain variation in patient outcomes, and typify 
care pathways with high- quality consistent patient 
outcomes. Documentary analysis of 20 anonymised 
British Orthopaedic Association hospital- initiated peer- 
review reports, and qualitative interviews with staff from 
four diverse UK hospitals providing hip fracture care, 
will identify barriers and facilitators to care delivery. 
The COVID-19 pandemic has posed a major challenge 
to the resilience of services and interviews will explore 
strategies used to adapt and innovate. This system- wide 
understanding will inform the development, in partnership 
with key national stakeholders, of an ‘Implementation 
Toolkit’ to inform and improve commissioning and delivery 
of hip fracture services.
Ethics and dissemination This study was approved: 
quantitative study by London, City and East Research 
Ethics Committee (20/LO/0101); and qualitative study by 
Faculty of Health Sciences University of Bristol Research 
Ethics Committee (Ref: 108284), National Health Service 
(NHS) Health Research Authority (20/HRA/71) and 
each NHS Trust provided Research and Development 
approval. Findings will be disseminated through 
scientific conferences, peer- reviewed journals and online 
workshops.
INTRODUCTION
Each year in the UK more than 70 000 older 
adults sustain a fragility fracture of the hip.1 
Strengths and limitations of this study
 ► A mixed- methodology approach will aid identifica-
tion of hospital- level organisational factors which 
explain adverse patient outcomes following hip 
fracture, and which are amenable to improvement 
across the UK.
 ► This study is novel in terms of its scale and the 
unique datasets used, which gives a rare opportu-
nity to robustly assess a complex system of care 
and the impacts this system has on patients with hip 
fracture and National Health Service (NHS) budgets.
 ► Use of quantitative, economic and qualitative analy-
sis will provide a system- wide understanding of the 
hip fracture care pathway, which will inform devel-
opment of an Implementation Toolkit, in partnership 
with key national stakeholders, to improve future 
service design.
 ► While multiple organisational datasets exist relevant 
to patient care in NHS hospitals, linking this NHS ac-
tivity to comprehensive social care data is not viable, 
hence, social care sequalae following hip fracture 
admission does not form part of this protocol.
 ► Currently the NHS is experiencing unprecedented 
pressures; the REducing unwarranted variation in 
the Delivery of high qUality hip fraCture services in 
England and Wales study will determine the most 
efficient management pathways for high cost pa-
tients, to improve patient outcomes and free NHS 
resources for use elsewhere.
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Such fractures are indicative of osteoporosis.1 Hip frac-
tures are costly to patients, relatives and the National 
Health Service (NHS), with a significant impact on 
quality of life2; a quarter of patients die within 1 year of 
hip fracture.3 Research has shown annual NHS medical 
costs from hip fracture exceed £1.2 billion.4
Patients sustaining hip fractures almost invariably 
require an operation, but patient care has many complex-
ities requiring contributions from various healthcare 
professionals at different time- points during an often- 
lengthy treatment journey. Many guidelines have been 
published trying to ensure all components of the care 
of patients sustaining hip fractures (hip fracture care) 
are provided consistently and to a high standard in all 
hospitals.1 5–7 While care has improved for some, there 
remains a great deal of variation across the UK in how 
health services deliver hip fracture care, so treatment still 
depends on where and when patients present to hospital. 
This unwarranted variation in care includes delays waiting 
for an operation, the type of operation performed, how 
much specialist help is provided, how soon physiotherapy 
is delivered, how thoroughly bone health is assessed, and 
more.
Substantial variation exists in how well patients recover 
after a hip fracture. Across the 172 hospitals currently 
providing hip fracture care in England and Wales, 
1 month after hip fracture the proportion of patients 
who have died varies from 2% to 14% between hospitals,8 
and the proportion who have been able to return home 
ranges from 29% to 85%.9 While overall 61% of patients 
are prescribed medication to reduce the chance of a 
further fracture in the future, this can vary enormously 
from 6% to 99.5% according to the hospital delivering 
hip fracture care.10 Time spent in hospital is highly vari-
able (the median length of stay in acute and postacute 
NHS care is 17 days, IQR 10–30 days) and the chance of 
being readmitted to hospital within 30 days because of 
a deterioration after discharge is high at 16%.11 12 While 
patient outcomes are partly explained by patient- level 
risk factors (eg, age and comorbidity), it is hypothesised 
that organisational factors are responsible for variation in 
the delivery of fracture care pathways and hence patient 
outcomes; these organisational factors are potentially 
modifiable.
It is important to understand how the set- up and organ-
isation of healthcare services affects patient recovery and 
outcomes after hip fracture. These services can vary in 
many ways, for example, types and grade of clinical staff; 
capacity to perform prompt operations; access to suitable 
rehabilitation services. It is expected these factors will 
explain variation in quality of care, patient outcomes and 
associated health costs. Understanding these will enable 
us to inform changes in healthcare services to minimise 
avoidable variation in fracture care and improve the 
quality of care for all patients across the country.
The 2020 COVID-19 pandemic has had an unprec-
edented impact on health service delivery across the 
NHS.13 14 Hospitals have needed to rapidly adapt and 
reorganise services to continue to deliver hip fracture 
care. To assist in service planning, NHS England15 16 and 
the British Orthopaedic Association (BOA)17 issued rapid 
guidance in March 2020 on the management of hip frac-
ture patients during the coronavirus pandemic.15–17 The 
limited evidence to date suggests that there has been wide 
variation in how hospitals have reconfigured services18 19 
and there is a lack of information about the impact of 
these changes on patient care.
The aim of this mixed- methods study is to determine 
the components of hospital service delivery of hip frac-
ture care that predict patient outcomes post hip fracture, 
and the direct health costs attributable to these organ-
isational factors. Furthermore, to understand factors 
that act as barriers and facilitators to the delivery of hip 
fracture care, including strategies that hospitals used to 
adapt and innovate hip fracture care delivery during the 
COVID-19 pandemic. Using these results, and working 
with key stakeholders, a toolkit will be developed, suitable 
for use by hospital managers, clinical leads and health-
care system leads across the country, to improve organ-
isational delivery of high- quality hip fracture services. 
Understanding strategies hospitals used to reconfigure 
care during the COVID-19 pandemic will inform develop-
ment of more resilient services in the future.
METHODS AND ANALYSIS
Quantitative study
Data sources: organisational level
Using a wide range of publicly available organisational- 
level service data, available at a hospital/trust provider 
level in England and Wales, including eight national 
audits and nine data series/ratings resources (table 1), 
data will be extracted to characterise each component 
of the hip fracture care pathway from admission to 
discharge (figure 1). The derived organisational metrics 
will be linked using hospital provider codes. Time- specific 
organisational metrics will be linked to patients by using 
the year in which they were admitted with their hip frac-
ture. Organisational metrics aim to quantify provision 
of emergency, orthopaedic, anaesthetic, orthogeriatric, 




Using routinely collected Hospital Episodes Statistics 
(HES) Admitted Patient Care (APC) data, that includes 
admissions to all English hospitals within the NHS (ie, 
excluding privately financed healthcare), patients will 
be linked by NHS Digital, the national health and social 
care data provider, to Office for National Statistics (ONS) 
Civil Registrations (deaths) mortality data for the same 
period. Similarly, in Wales the NHS Wales Informatics 
Service will link patients with hip fractures in the Patient 
Episode Database for Wales (PEDW) to ONS mortality 
data. The resulting HES- ONS and PEDW- ONS patients’ 
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Table 1 Organisational datasets included in the REducing unwarranted variation in the Delivery of high qUality hip fraCture 




and Wales Available years Type of data available Ref
NHFD Benchmark 
Summary
Combined 2016, 2017, 2018, 2019 Summary of hospital performance in three 
areas: assessment, surgery, outcomes
31
NHFD Best Practice Combined April 2016 to March 2019 The charts provide feedback on service 









(excluding BP and KPI)
Combined April 2016 to March 2019 Charts with information on:
 ► Anaesthesia.
 ► Overall performance.
 ► Patient safety.




Combined 2016–17, 2017–2018, 2018–2019 Annual survey of facilities and performance 
of trauma units in England, Wales and 
Northern Ireland
8 9 44
National Audit of 
Inpatient Falls
Combined 2017 and 2019 Organisational audit
 ► Background.
 ► Policies, protocols and paperwork.
 ► Leadership and service provision.
Clinical audit (snapshot of the care)
 ► Evidence of assessment and intervention 
in case notes.





Combined 2017 Review of physiotherapy rehabilitation for 




Combined 2016, 2017, 2018, 2019 National audit of secondary fracture 




England 2016, 2017, 2018, 2019 CQC independent regulator of health and 
adult social care in England
51
NHS Staff Survey 
Themes
England 2016, 2017, 2018, 2019 Reports how NHS staff in England 





England April 2016 to March 2019 Monthly numbers of NHS Hospital staff 
groups working in Trusts in England as 
headcount and full- time equivalents
53
NHS Bed Availability 
and Occupancy Data—
Overnight
England April 2016 to March 2019 A quarterly collection from all NHS 
organisations that operate beds, open 
overnight or day only. It collects the total 
number of available bed days and the total 






England April 2016 to March 2019 The number of operating theatres and 







England April 2016 to March 2019 A&E attendances and emergency admission 
monthly statistics, NHS and independent 
sector organisations in England
56
NHS Staff Wales September 2016–2018, March 2019 Assignment count and full- time equivalent 
of directly employed NHS staff by grade 
and area of work
57
NHS Beds by 
Specialty: Availability 
and Occupancy Data
Wales 2016–2017, 2017–2018, 2018–2019 NHS Beds by organisation and specialty 58
Continued
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data extracts will then be linked to data from the UK’s 
National Hip Fracture Database (NHFD) for the admis-
sion. The NHFD, active since 2007, is a clinically led web- 
based audit of hip fracture care and secondary fracture 
prevention in England, Wales and Northern Ireland, data 
collected have informed the Best Practice Tariff (BPT) 
for hip fracture care since 2010.20 21
HES/PEDW provide information on patient demo-
graphics, admission, discharge, clinical diagnoses using 
International Classification of Diseases Tenth Revision 
(ICD-10) disease codes, and Classification of Interventions 
and Procedures version 4 codes.22 ONS mortality data 
are obtained from death certificates of all registered 
deaths in England and Wales,23 thus capturing deaths 
that occurred inside and outside of hospital. Each NHFD 
record includes information on patient demographics, 
anaesthetic risk grade, type of hip fracture and surgical 
operation performed.
Hip fracture admissions will be identified using ICD-10 
codes for fractured neck of femur (S72.0), pertrochan-
teric fracture (S72.1), subtrochanteric fracture (S72.2) 




and Wales Available years Type of data available Ref
NHS ED Attendances 
and Emergency 
Admissions
Wales April 2016 to March 2019 Reports performance against waiting 
times targets by hospital. (Requested 
and received from NWIS directly, total 
emergency admissions.)
59
A&E, accident and emergency; BP, Best Practice; CQC, Care Quality Commission; ED, Emergency Department; KPI, Key Performance 
Indicator; NHFD, National Hip Fracture Database; NHS, National Health Service; NWIS, NHS Wales Informatics Service.
Table 1 Continued
Figure 1 Hip fracture care pathway and domains of organisational- level data. Hip fracture care pathway flows from prehospital 
care, through the hospital superspell, through to any occurring hospital activity in the year after hip fracture. Organisational 
domains are indicated by green boxes, and these are mapped to the pathway.
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population will consist of index cases of hip fracture (ie, 
the first occurrence of hip fracture), among English or 
Welsh residents (male and female) aged 60 years or more, 
admitted to an English or Welsh hospital between 1 April 
2016 and 31 March 2019.
Patient-level outcomes
For each patient with an index hip fracture, all HES APC, 
outpatient clinic and emergency department (ED) atten-
dance data in England, and similar PEDW data in Wales, 
will be analysed for the subsequent 12 months enabling 
post- fracture follow- up (thus the last follow- up will 
complete 31 March 2020). Patient outcome measures will 
include: (i) cumulative mortality at 30 days and 1 year, (ii) 
acute NHS ‘super- spell’ (defined as the index hip fracture 
admission, plus if applicable, planned hospital transfers 
for elective care and/or subsequent unplanned hospital 
transfers for emergency care), (iii) return to original resi-
dence at discharge, (iv) emergency 30- day readmissions 
(defined as an emergency all- cause admission to any 
English/Welsh NHS hospital that occurred within 30 days 
of hospital discharge following a hip fracture superspell), 
(v) mobility at 120 days, (vi) return to original residence 
at 120 days, (vii) osteoporosis treatment to reduce future 
fracture risk, (viii) re- fracture/re- operation, (ix) the total 
number of days spent in hospital in the year following hip 
fracture, informing (x) total direct health costs attribut-
able to hip fracture (see below).
Health cost outcomes
HES data reports Healthcare Resource Groups assigned 
to each finished consultant episode in a hospital spell 
via the Casemix Grouper Software (HRG4+).24 HRGs 
are standard groups of clinically similar treatments that 
consume a common set of healthcare resources. HRGs 
will be valued using the most up- to- date prices available 
from Department of Health and Social care reference 
costs for NHS trusts, including a per diem costing for bed 
days in excess of those expected for a standard tariff.25
Statistical analysis of outcomes
Using a systematic approach, organisational factors will be 
identified which predict patient- level outcomes including 
associated health costs. Using a ‘top- down’ approach, 
defining a priori indicator groupings (domains), 
informed by NHFD BPT variables with stakeholder 
consensus, key indicators will be identified predicting 
patient outcomes. Clinicians will undertake expert panel 
review to select potential explanatory organisational- level 
variables. The flow diagram (figure 2) illustrates this 
review process which will be repeated across all organisa-
tional data sources.
Further expert- driven data reduction will involve exam-
ining the prevalence and correlation of selected organ-
isational variables with each outcome, to finalise the 
dataset for multi- level models. Those variables selected 
for inclusion will be mapped to one or more domains of 
hip fracture care (eg, admission, anaesthesia, delirium 
prevention, governance, annual hospital admissions 
for hip fracture, inpatient falls, nutrition, orthogeria-
trician assessment, pain management, rehabilitation, 
surgery, therapy provision and ward staffing and care (see 
figure 3). Each organisational variable will be assigned as 
relevant to one or more patient outcomes.
Multi- level regression modelling will identify organ-
isational components of the hip fracture care pathway 
responsible for the greatest variation in patient outcomes 
and costs. The hierarchical data structure consists of 
patients (level 1), nested within hospitals (level 2). Multi-
level regression models will describe the association of 
organisational- level factors on patient- level outcomes, 
while adjusting for patient case- mix, and allow assessment 
of interactions between patient- level and organisational- 
level factors. Case- mix adjustment will be the same as that 
used in the NHFD clinical audit26 and will include age, 
sex, residence prior to admission, pre- fracture mobility, 
fracture type and American Society of Anaesthesiologists 
grade27 (figure 3). Further adjustment will explore inclu-
sion of the following additional patient- level variables 
as part of the case- mix adjustment: area- level depriva-
tion, quantified by the Index of Multiple Deprivation28; 
Figure 2 Flow diagram used to determine organisational 
data metrics. *Include if two or more of the four reviewers 
categorised variable as ‘include’ or ‘possible’, otherwise 
exclude; any lack of consensus resolved by a third reviewer 
(the principal investigator). Shaded boxes indicate variables 
which will be included in analyses.
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comorbidity, quantified by the Charlson comorbidity 
index29 and frailty, quantified by the hospital frailty risk 
score.30
Having identified the proportion of variance in a given 
patient- level outcome, not explained by patient- level 
factors (ie, case- mix), the between- hospital variability 
explained by fixed organisational effects will be quanti-
fied, that is, the proportion of between- hospital variance 
explained by the configuration of specific services. For 
each outcome, domains added sequentially to a multi- 
level model (after case- mix adjustment) will be fitted to 
identify those domains which have the greatest effect 
and predict patient- level outcomes. From the selected 
domains the most influential organisational variables will 
be identified.
Statistical analysis of costs
Patient costs will be adjusted for baseline costs (ie, the 
healthcare costs incurred in the year prior to hip frac-
ture) and patient case- mix as detailed earlier. Adjusted 
estimates of patient costs will be reported as aggregate 
costs and costs disaggregated by initial hospital superspell 
and readmissions/further NHS care. Different pathways 
of care following hip fracture will be identified by expert 
consensus agreement for comparative cost analyses.
The multi- level model will be used to determine how 
health costs relate to organisational factors and patient 
outcomes, identifying organisational factors associated 
with highest/lowest costs. Cost profiles will be calculated 
for different hip fracture care pathway models, facili-
tating budget impact analyses (eg, estimate potential NHS 
savings should hip fracture care pathway models change). 
Costed scenarios will inform the Implementation Toolkit 
cost- benefit calculator.
Qualitative study
Service delivery stakeholder interviews
For the qualitative interviews four hospitals will be 
selected and approached. For English hospitals, BPT 
(2017–2019) and Key Performance Indicators (2018) 
will be collated, and 25 hospitals with the most and 25 
with the least variable scores selected.31 Hospitals will be 
excluded if (i) they are major trauma centres (as these 
hospitals may differ significantly from the majority of hip 
fracture hospitals which are not major trauma centres); 
(ii) they have recently merged or moved location; (iii) 
Figure 3 Structure of the multi- level models used in the statistical analyses in the REducing unwarranted variation in the 
Delivery of high qUality hip fraCture services in England and Wales study. aSame as patient- level National Hip Fracture 
Database clinical audit case- mix variables.26 ASA, American Society of Anaesthesiologists.
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they are participating in the hip fracture quality improve-
ment programme (as practices in these hospitals are 
likely to be changing); (iv) they are located local to the 
study team (eg, Bristol, Bath) (to avert any conflict of 
interest within the research team); (v) if data quality 
is poor (as measured by NHFD report1) ; (vi) or if the 
hospital manages low volumes of hip fractures (annual 
hip fracture admissions less than the fifth percentile). 
From the remaining pool, hospitals will be selected 
to provide a diverse range in terms of 30- day mortality 
trend (2017–2018), BPT trend (2017–2019), hospital size 
(large/medium) and geographical location (eg, city/
rural/coastal, north/south of England).
A qualitative interview study will characterise the organ-
isation of hip fracture services and identify barriers and 
facilitators to the implementation of key components of 
fracture care. In addition, strategies that hospitals used 
to adapt and innovate hip fracture care delivery, during 
the COVID-19 pandemic, along with barriers and facil-
itators to the reorganisation of services in 2020 will be 
ascertained. Four hospitals have been identified that 
encompass variation in a range of characteristics as listed 
above, aiming to identify varied service configurations.32 
Studying care in these settings will enable us to capture 
the experiences of those delivering different models of 
hospital care.
At the four participating hospitals, 1:1 in- depth inter-
views will be conducted with stakeholders involved in 
the organisation and delivery of hip fracture services, 
including orthogeriatricians, orthopaedic surgeons, 
anaesthetists, emergency medicine physicians, physio-
therapists, occupational therapists, trauma nurses and 
discharge and service managers. Interviews will be carried 
out either remotely or in person (according to infection 
control constraints) with informed consent, including 
consent to audio- recording. An estimated 10–15 profes-
sionals will be interviewed at each hospital site, totalling 
around 40–60 professionals across the study. However, 
final sample size will be determined when data saturation 
is achieved; that is, when no new themes or subthemes 
are identified in the data.33 Interviews will be conducted 
using a topic guide with a list of themes and subthemes 
to guide discussions. This will enable us to compare and 
contrast stakeholder views and provide flexibility to pursue 
emerging ideas.34 To understand contextual factors that 
impact on service implementation, study design and anal-
ysis will be informed by Implementation Science. Imple-
mentation Science comprises theories or frameworks that 
have been used to help understand factors that help or 
hinder the delivery of complex interventions such as hip 
fracture care.35–38 The topic guide has been devised by the 
study team with Patient and Public Involvement (PPI). 
PPI identified patient priorities during the first wave of 
COVID-19, which will enable exploration of how services 
adapted to meet these needs. Four to six pilot interviews 
will inform topic guide refinement. If refinements are 
minor, initial pilot interviews will contribute to the main 
analysis.
Interviews will be audio- recorded, transcribed and 
anonymised. Transcripts will be imported into NVivo 
qualitative software and analysed using an inductive 
thematic analysis to identify key themes and subthemes 
in the data.39 Following this, an abductive approach will 
be used whereby themes/subthemes will be transposed 
onto concepts from Implementation Science theory.40 To 
ensure rigour, 20% of transcripts will be independently 
analysed in duplicate and themes reviewed and refined to 
agree a themes list.
Documentary analysis of BOA reports
To complement the qualitative interviews and to under-
stand the common themes and solutions (‘lessons learnt’) 
in relation to provision of hip fracture care, qualitative 
content analysis will be conducted of anonymised detailed 
hospital- initiated peer- review process (PRP) reports from 
22 hospitals (all that have been conducted by the BOA to 
2019). PRP reports, produced by the BOA over the period 
2013–2019, were delivered when UK hospital service 
leads requested a BOA ‘peer- review’ to improve their hip 
fracture service. Each PRP report includes interviews with 
a range of staff (eg, clinical directors, clinicians, nurses, 
therapists, anaesthetists, ED personnel and managers). 
PRP reports are structured encompassing appraisal of the 
full hip fracture care pathway: ED, orthopaedics, anaes-
thetics, theatre activity, orthogeriatrics, nursing, thera-
pies, discharge planning, collection of NHFD audit data 
and governance structures. Reports list all areas of good 
practice and highlight issues where improvements are 
achievable. PRP reports include a series of recommenda-
tions made by the multi- disciplinary assessment team with 
numerated action points. Reports will be imported into 
NVivo qualitative analysis software and will be analysed 
thematically to identify barriers and facilitators to imple-
mentation of quality hip fracture services.39 Themes iden-
tified in the documentary analysis will be mapped onto 
those from the qualitative interviews. To illustrate this 
process, data will be displayed on charts using the frame-
work approach to data organisation.41 Written accounts 
will then be generated. Recommendations will inform 
choice of domains in quantitative analyses and of subse-
quent Implementation Toolkit development.
Implementation Toolkit development
In 2015 the Royal (formerly National) Osteoporosis 
Society (ROS), developed a Fracture Liaison Service (FLS) 
Toolkit to aid FLS commissioning of new or improved 
services.42 It was designed to support business case devel-
opment, saving time for service leads and commissioners, 
and has been highly successful. Since 2015 the Service 
Improvement Team at the ROS have supported the 
development of 34 new FLSs. These new services cover a 
patient population of more than 12 million people and it 
has been estimated that 5 years following implementation 
of all these services, approximately 3854 hip fractures 
will have been prevented. Approximately 60% of the UK 
population can access an FLS, and the ROS is currently 
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working with sites all over the UK to ensure that current 
services are delivering in line with national clinical guide-
lines, and supporting sites that do not have an FLS at 
present. The ROS has acquired extensive experience in 
service improvement, refining tools based on user feed-
back, and continuing to support quality improvement.
Working with the ROS, the BOA and other stake-
holders, a Hip Fracture Implementation Toolkit will be 
codeveloped, focusing on inpatient hip fracture services, 
prioritising organisational factors identified from our 
quantitative and qualitative results which contribute to 
poor and/or highly variable patient outcomes post hip 
fracture. All acute NHS hospitals currently have a hip 
fracture care pathway; hence, the toolkit will include a 
step- by- step guide to improve and implement changes 
to current services. It will be made available online and 
provide a series of instructions and guides (ie, ‘tools’) for 
managers, clinical leads and healthcare system leads to 
use to improve their hospital hip fracture services, encom-
passing service redesign/restructuring, organisational 
cultural change, and approaches to improve efficient 
use of limited healthcare resources. Tools will include a 
service improvement guide, business case resources, a 
cost calculator and a project plan.
Patient and public involvement
This study has been developed in collaboration with 
the University of Bristol Musculoskeletal Research Unit 
(MRU) PPI group comprising members who have had/
are having treatment for osteoporosis and/or fractures, 
who meet (currently virtually) every 3 months to input 
into the design and conduct of MRU research projects. 
They have guided development of the project proposal, 
informing prioritisation of research questions, drafting 
plain English text, changing language and wording within 
study texts; they have informed methods adaptation in 
response to COVID-19 in 2020. The group will provide 
ongoing support throughout the study, addressing (i) key 
patient and carer questions and priorities, (ii) the inter-
pretation and relevance of results and (iii) communica-
tion of findings. ‘Taking the research’ to patients in the 
involvement group rather than asking patients to attend 
research management meetings has improved engage-
ment and fosters strong collaboration and respect.43 
Meetings will be organised by an experienced PPI coordi-
nator (KW), who will facilitate meetings, provide ongoing 
support and tailored development to patient members, 
and advise on good practice.
ETHICS AND DISSEMINATION
Ethics and governance
The quantitative study has research approvals from 
NHS Health Research Authority—London City and East 
Research Ethics Committee (20/LO/0101, 11/02/2020); 
Royal College of Physicians (RCP) Falls and Fragility 
Fracture Audit Programme (FFFAP) (FFFAP/2018/003, 
11/12/2019) and Healthcare Quality Improvement 
Partnership approval (HQIP330, 18/06/2020); NHS 
Wales Informatics Service (NWIS) (30941, 13/03/2020) 
and an NHS Digital Data Sharing Agreement (DARS- NIC-
334549- B1Y6X- v1.4, 28/09/2020). The qualitative study 
has been approved for conduct by the Faculty of Health 
Sciences University of Bristol Research Ethics Committee 
(Ref: 108284, 9/9/2020) and by the NHS Health Research 
Authority (20/HRA/71, 10/9/2020). Each NHS Trust 
has provided Research and Development approval.
Dissemination
Findings will be disseminated through scientific confer-
ences, peer- reviewed publications and online implemen-
tation workshops. Results will be fed back to the scientific 
committee with oversight of the NHFD as well as the BOA. 
Reports will be provided to each hospital in England and 
Wales summarising findings, and the PPI group will be 
involved in all stages of dissemination. Working with the 
ROS, dissemination materials will be developed for its 
membership network (n=20 000). The Implementation 
Toolkit will be hosted and made freely available by the 
ROS website.
CONCLUSION
Through the use of mixed methodology, this study will 
determine the components of hospital service delivery 
which account for poor patient outcomes post hip frac-
ture and identify which service configurations are most 
efficient and successful. Quantitative analyses will allow us 
to distinguish patient outcomes explained by the health of 
the patient themselves, versus outcomes attributable to the 
hospital services which they encounter. Domains of hip frac-
ture care which are most critical for a wide range of patient 
outcomes over 12 months, will be identified. The direct 
health costs ascribed to each patient in the year after hip 
fracture, accounting for costs in the year prior to fracture, 
will be calculated. Thus, hospital expenditure attributable 
to different components of hip fracture service delivery will 
be calculated. These financial calculations will inform cost 
calculators in the Implementation Toolkit. The Toolkit will 
be a novel, freely available online resource for managers, 
clinical leads and healthcare system leads to use to improve 
their hip fracture service.
The qualitative analysis will aid understanding of the 
organisational processes that help or hinder the imple-
mentation of key components of hip fracture services. In 
addition, it will identify strategies that hospitals have used 
to adapt and innovate hip fracture care delivery during the 
COVID-19 pandemic. Knowledge gained will inform toolkit 
development, aiming to assist services in overcoming 
organisational barriers when designing and implementing 
sustainable high- quality fracture services, and improve 
patient care. Understanding strategies hospitals used to 
reconfigure care during the COVID-19 pandemic will 
provide learning towards the development of more robust 
and resilient hip fracture services in the future. This infor-
mation is likely to be transferrable to other services.









pen: first published as 10.1136/bm





9Patel R, et al. BMJ Open 2021;11:e049763. doi:10.1136/bmjopen-2021-049763
Open access
In conclusion, a system- wide understanding of sources 
of variation in hip fracture care delivery and the effects 
on patient outcomes will inform service- level interven-
tions to reduce unwarranted variation, maximise health 
equity and ultimately improve patient experience. The 
study aims to show effective hip fracture care is more 
efficient, realising cost- savings in hospital bed- days poten-
tially re- directable to other services. This project is novel 
in terms of its scale and the unique datasets which gives 
us a rare opportunity to robustly assess what is a complex 
system of care and the very real impacts this system has 
on patients. Findings will inform future commissioning/
service planning priorities for hip fracture care, inform 
national review processes for hip fracture services and, 
together with a new online toolkit, this programme aims 
to minimise avoidable variation in hip fracture care and 
improve the quality of care for patients across the UK.
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